- Home
- PTPI vs PRFX Comparison
PTPI vs PRFX Comparison
Compare PTPI & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTPI
- PRFX
- Stock Information
- Founded
- PTPI 2020
- PRFX 2007
- Country
- PTPI United States
- PRFX Israel
- Employees
- PTPI N/A
- PRFX N/A
- Industry
- PTPI Biotechnology: Pharmaceutical Preparations
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- PTPI Health Care
- PRFX Health Care
- Exchange
- PTPI Nasdaq
- PRFX Nasdaq
- Market Cap
- PTPI 3.1M
- PRFX 2.7M
- IPO Year
- PTPI N/A
- PRFX 2020
- Fundamental
- Price
- PTPI $0.27
- PRFX $3.20
- Analyst Decision
- PTPI
- PRFX Hold
- Analyst Count
- PTPI 0
- PRFX 1
- Target Price
- PTPI N/A
- PRFX N/A
- AVG Volume (30 Days)
- PTPI 1.2M
- PRFX 1.1M
- Earning Date
- PTPI 03-31-2025
- PRFX 08-15-2024
- Dividend Yield
- PTPI N/A
- PRFX N/A
- EPS Growth
- PTPI N/A
- PRFX N/A
- EPS
- PTPI N/A
- PRFX N/A
- Revenue
- PTPI $4,022,389.00
- PRFX N/A
- Revenue This Year
- PTPI N/A
- PRFX N/A
- Revenue Next Year
- PTPI $0.76
- PRFX N/A
- P/E Ratio
- PTPI N/A
- PRFX N/A
- Revenue Growth
- PTPI N/A
- PRFX N/A
- 52 Week Low
- PTPI $0.22
- PRFX $0.43
- 52 Week High
- PTPI $2.27
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- PTPI 39.88
- PRFX 49.57
- Support Level
- PTPI $0.30
- PRFX $2.87
- Resistance Level
- PTPI $0.30
- PRFX $3.58
- Average True Range (ATR)
- PTPI 0.03
- PRFX 0.51
- MACD
- PTPI -0.01
- PRFX -0.02
- Stochastic Oscillator
- PTPI 5.23
- PRFX 11.76
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.